Osteoporosis and atherosclerosis in chronic renal failure

Osteoporosis International

Volumn 7, Issue SUPPL. 3, 1997, Pages

  Nishizawa, Y ^a   Morii, H ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; LIPOPROTEIN METABOLISM; METABOLIC BONE DISEASE; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; AORTIC DISEASES; ARTERIOSCLEROSIS; BONE AND BONES; BONE DENSITY; CALCINOSIS; CALCIUM; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE;

EID: 0031438208     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03194370     Document Type: Article

References (52)

1. Rifkind BM, Tamir I, Heiss G, et al. Distribution of high density and other lipoproteins in selected LRC prevalence study populations: a brief survey. Lipids 1978;14:105-12.
2. Stevenson JC. Osteoporosis and cardiovascular disease in women: converging path? Lancet 1990;336:1121-2.
3. Browner WS, Sooley DG, Vogt TM, et al. Non-trauma mortality in elderly women with low bone mineral density. Lancet 1991;338:335-8.
4. Slatopolsky E, Hruska K, Klahr S. Disorders of phosphorus, calcium, and magnesium metabolism. In: Schrier RW, Gottschalk CW, editors. Diseases of the kidney. Boston: Little, Brown, 1993:2599-644.
5. Felsenfeld AJ, Llach F. Parathyroid gland function in chronic renal failure. Kidney Int 1993;43:771-89.
6. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
7. Kramer P, Broyer M, Brunner FP, et al. Combined report on regular dialysis and transplantation in Europe, XII, 1981. Proc Eur Dial Transplant Assoc 1983;19:4-59.
8. Elkeles A. A comparative radiological study of calcified atheroma in males and females over 50 years of age. Lancet 1957;2:714-5.
9. Anderson JB, Barnett E, Nordin BEC. The relation between osteoporosis and aortic calcification. Br J Radiol 1964;37:910-2.
10. Watson KE, Demer LL. The atherosclerosis-calcification link? Curr Opin Lipidol 1996;7:101-4.
11. Banks LM, Lees B, Macsweeney JE, et al. Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest 1994;24:813.
12. Smith RW, Rizek J. Epidemiologic studies of osteoporosis in women of Puerto Rico and Southern Michigan with special reference to age, race, national origin and to other related findings. Clin Orthop 1966;45:31-48.
13. Boukhris R, Becker KL. Calcification of the aorta and osteoporosis: a roentgenographic study. JAMA 1972;219:1307-11.
14. Huttmann A, Pasztor P. Die verkalkende Aortenstenose als osteogene Kardiopathie. Z Ges Inn Med 1968;23(Suppl):145-7.
15. Laroche M, Pouilles JM, Ribot C, et al. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 1994;13:611-4.
16. Jie K-SG, Bots ML, Vermeer C, et al. Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study. Atherosclerosis 1995;116:117-23.
17. Jie K-SG, Bots ML, Vermeer C, et al. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 1996;59:352-6.
18. Levy RJ, Gundberg C, Scheinman R. The identification of the vitamin K-dependent bone protein osteocalcin as one of the γ-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaques and mineralized heart valves. Atherosclerosis 1983;46:49-56.
19. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990;266:625-36.
20. Levy RJ, Howard SL, Oshry LJ. Carboxyglutamic acid (Gla) containing proteins of human calcified atherosclerotic plaque solubilized by EDTA. Molecular weight distribution and relationship to osteocalcin. Atherosclerosis 1986;59:155-60.
21. Shanahan CM, Cary NR, Metcalfe JC, et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaque. J Clin Invest 1994;93:2393-402.
22. Ikeda T, Shirasawa T, Esaki Y, et al. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993;92:2814-20.
23. Bostrom K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-9.
24. Shioi A, Nishizawa Y, Jono S, et al. γ-Glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995;15:2003-9.
25. Jono S, Nishizawa Y, Shioi A, et al. Parathyroid hormone-related peptide as a local regulator of vascular calcification: its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:1135-42.
26. Watson KE, Bostrom K, Ravindranath R, et al. TGF-γ1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-13.
27. Demer LL, Watson KE, Bostrom K. Mechanism of calcification in atherosclerosis. Trends Cardiovasc Med 1994;4:45-9.
28. Statistical Committee (Maeda K, Chief). An overview of regular dialysis treatment in Japan as of December 31, 1993. Annual Report of the Japanese Society for Dialysis Therapy, 1994.
29. Ritz E, Augustin J, Brommer J, et al. Should hyperlipidemia of renal failure be treated? Kidney Int 1985;28(Suppl 17):584-7.
30. Kooman JP, Leunissen ML. Cardiovascular aspects in renal disease. Curr Opin Nephrol Hypertens 1993;2:791-7.
31. Vincenti F, Amend W, Abele N, et al. The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 1980;68:363-9.
32. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: insight from coronary angiography. Kidney Int 1984;25:635-59.
33. Kawagishi T, Nishizawa Y, Konishi Y, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995;48:820-6.
34. Kudoh Y, Iimura O. Study on the atherosclerosis mechanism in chronic hemodialysis. Jpn Circ J 1987;51:631-41.
35. Burdick L, Periti M, Salvaggio A, et al. Relation between carotid artery atherosclerosis and time on dialysis, a non-invasive study in vivo. Clin Nephrol 1994;42:121-6.
36. Kamm KE, Stull JT. The function of myosin and myosin light chain kinase phosphorylation in smooth miscle. Annu Rev Pharmacol Toxicol 1985;25:593-620.
37. Resnick LM. Uniformity and diversity of calcium metabolism in hypertension. Am J Med 1987;82(Suppl 1B): 16-23.
38. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316099 white men. Arch Intern Med 1992;152:56-64.
39. Friedman SA, Rosen H. Uremia and cardiovascular mortality. Ann Intern Med 1974;81:696-7.
40. Attmann P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991;39(Suppl):S16-23.
41. Eisenberg S. High-density lipoprotein metabolism. J Lipid Res 1984;25:1017-83.
42. Shoji T, Nishizawa Y, Kawagishi T, et al. Secondary hyperparathyroidism, decreased hepatic triglyceride lipase, elevated intermediate density lipoprotein and atherosclerosis in hemodialysis patients. Nephron 1997 (in press).
43. Shoji T, Nishizavva Y, Nishitani H, et al. Impaired high density lipoprotein metabolism in chronic renal failure patients. Kidney Int 1992;41:1653-61.
44. Akmal M, Kasim SE, Solima AR, et al. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 1990;37:854-8.
45. 3 treatment on lipid levels in uremic hemodialysis patients. Int Artif Organ 1992;15:704-7.
46. 3 on induction of scavenger receptor and differentiation of 12-o-tetradecanoylphorbol-13-acetate-treated THP-1 human monocyte like cells. J Cell Physiol 1995; 165:547-55.
47. Ando M, Lundkvist I, Bergstrom J, et al. Enhanced scavenger receptor expression in monocyte-macrophages in dialysis patients. Kidney Int 1996;49:773-80.
48. Hagiwara S, Aratani H, Miki T, et al. Total and regional bone mineral content in hemodialysis patients. Ann Nucl Med 1994; 8:41-6.
49. Lindgard B, Johnell O, Nilsson BE, et al. Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron 1985;39:122-9.
50. Asai K, Miura S, Kawahara H, et al. A comparative study of atherosclerosis and osteopenia in elderly and young hemodialysis patients. Aging 1991;3:79-87.
51. Krauss RM, Lindgren FT, William PT, et al. Intermediate-density lipoproteins and progression of coronary disease in hypercholesterolemic men. Lancet 1987;2:62-6.
52. Shoji T, Nishizawa Y, Kawagishi T, et al. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis. Atherosclerosis. 1997;131:229-36.